The Texas Collaborative Center for Hepatocellular Cancer: Reducing Liver Cancer Mortality in Texas Through Coordination, Collaboration and Advocacy

Authors

Ariel C Harrison
Fasiha Kanwal
Sumeet K Asrani
Aaron P Thrift
Chris I Amos
Maria L Jibaja-Weiss
Jane R Montealegre
Jessica P Hwang
Amit G Singal
Hashem B El-Serag

Publication Date

1-1-2022

Journal

Frontiers in Oncology

DOI

10.3389/fonc.2022.953933

PMID

36059708

PMCID

PMC9437299

PubMedCentral® Posted Date

8-19-2022

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Keywords

collaborative center, Texas, hepatocellular cancer (HCC), liver cancer, cancer prevention

Abstract

Texas has the highest age-adjusted incidence rate of hepatocellular carcinoma (HCC) in the United States. To address cancer prevention and early detection through research, Cancer Prevention and Research Institute of Texas (CPRIT) has funded the Texas Collaborative Center for Hepatocellular Cancer (TeCH) to facilitate liver cancer research, education and advocacy activities. This paper describes the organizational structure, program measures, the actions completed and future plans of TeCH. This center is comprised of several cores and committees including the Administrative Core, Steering Committee, Data and Biospecimen Core, Scientific Committee, Clinical Network Committee, and the Community Outreach Committee. Each core and committee provide its own level of connectivity and necessary research support. We have developed and published a TeCH Framework, a conceptual model designed for improving primary and secondary prevention of HCC. TeCH and its committees facilitate connections and collaborations among HCC researchers and clinicians, healthcare leaders, biotechnology companies and the public to reduce liver cancer mortality in Texas by 2030.